ABSTRACT
Resumen: Objetivo: Evaluar la prevalencia de anticuerpos antiparotiditis en niños y adolescentes de México, a dos años de haberse introducido la vacuna SRP. Material y métodos: Se estudiaron 2111 niños (1-9 años) y 2484 adolescentes (10-19 años). Se evaluaron anticuerpos IgG con un kit comercial de ELISA indirecto. Resultados: La seroprevalencia fue 70.6% (IC95% 69.3-71.9) y resultó mayor en adolescentes (83.0%, IC95% 81.5-84.5) que en niños (56.0%, IC95% 53.9-58.11) (OR 3.83; IC95% 3.34-4.39, p=0.0000000). Los niños de 1 a 2 y de 6 a 9 años, que a partir de 1998 formaron parte del grupo blanco de vacunación vs parotiditis, tuvieron mayor seroprevalencia que el grupo de 3 a 5 años no vacunado. Conclusiones: La seropositividad en niños de 1 a 2 y de 6 a 9 años fue probablemente atribuible a vacunación durante 1998-2000 y la de otros grupos etarios a exposición natural relacionada con el tiempo transcurrido en cada cohorte de nacimientos hasta el reclutamiento al estudio.
Abstract: Objective: To assess the prevalence of mumps antibodies in children and adolescents of Mexico, two years after the introduction of the mumps-containing vaccine MMR. Materials and methods: Evaluation of IgG antibodies with a commercial kit of indirect ELISA. Results: 2111 children (1-9 years) and 2484 adolescents (10-19 years) were studied. The overall antibody seroprevalence was 70.6% (95% CI 69.3-71.9), being higher in adolescents (83.0%, 95%CI 81.5-84.5) than in children (56.0%, 95%CI: 53.9-58.11) (OR 3.83, 95%CI 3.34-4.39, p=0.0000000). Children 1 to 2 and 6 to 9 years who were part of the target group of mumps vaccination since 1998, they had higher seroprevalence than the group of 3 to 5 years unvaccinated. Conclusions: Seropositivity in children aged 1 to 2 and 6 to 9 years was probably attributable to vaccination during 1998-2000 and in other age groups to natural exposure related to time elapsed in each birth cohort until the study recruitment.
Subject(s)
Humans , Male , Female , Child, Preschool , Child , Adolescent , Immunoglobulin G/blood , Measles-Mumps-Rubella Vaccine , Immunogenicity, Vaccine , Antibodies, Viral/blood , Mumps virus/immunology , Immunoglobulin G/immunology , Enzyme-Linked Immunosorbent Assay , Seroepidemiologic Studies , Vaccination , MexicoABSTRACT
Objetivo. Identificar el grupo poblacional en el que se concentra el incremento de sífilis ocurrido durante los últimos años. Material y métodos. A partir de información obtenida de los Anuarios de Morbilidad de la Secretaría de Salud, se conformaron diversas bases de datos con información desagregada por sexo, grupo de edad y entidad federativa durante el periodo de 2003 a 2013. Mediante análisis de regresión lineal, se estimó el incremento con intervalos de confianza a 95%; se evaluaron los cambios a través del tiempo en los diversos grupos poblacionales analizados. Resultados. A partir de 2010 hay un incremento de 0.67 casos por 100000 habitantes (IC95% 0.30-1.04) entre los hombres, que se concentra en individuos de 20 a 24 y de 25 a 44 años. Las mayores incidencias de sífilis adquirida se reportaron en los dos últimos años: 2012 y 2013; este último año registró una incidencia 1.85 veces mayor a la reportada en el año 2003. Entidades como Aguascalientes, Distrito Federal, Durango, México, Oaxaca, Puebla, Quintana Roo, Yucatán y Zacatecas reportaron incrementos de sífilis adquirida durante el periodo de estudio. Conclusión. La sífilis adquirida aparentemente está reemergiendo en México entre hombres jóvenes, incremento que no es homogéneo en el país, por lo que es necesario focalizar medidas de intervención para esta infección de transmisión sexual.
Objective. To identify the population group in which syphilis increase was concentrated. Materials and methods. The information was collected from the Mexico health statistical yearbooks. The information disaggregated by sex, age group and state during the period 2003 to 2013 was used to form different databases. Linear regression analysis with confidence interval at 95% was used to evaluate changes over time in different population groups. Results. An increase of 0.67 cases per 100000 population (95%CI 0.30-1.04) in men was detected from 2010. The increase was concentrated in each group of 20-24 and 25-44. The highest incidence of acquired syphilis was reported in the last two years: 2012 and 2013. The last year reported a 1.85 times higher incidence than reported in 2003. Aguascalientes, Distrito Federal, Durango, Mexico, Oaxaca, Puebla, Quintana Roo, Yucatan and Zacatecas reported that syphilis increased during the study period. Conclusion. Acquired syphilis may be reemerging in our country among young men; this increase is not uniform across the country, it is necessary to focus intervention measures for this sexually transmitted infection.
Subject(s)
Humans , Male , Female , Adult , Young Adult , Syphilis/epidemiology , Linear Models , Morbidity/trends , Databases, Factual , Sex Distribution , Community-Acquired Infections/epidemiology , Age Distribution , Geography, Medical , Mexico/epidemiologyABSTRACT
Objectives: To determine the prevalence of HPV and the risky sexual behaviors associated to it in a sample of male college students, taking into account genotype and viral load. Methods: From 2002 to 2003, male students from the Autonomous University of Morelos State completed a questionnaire and provided self-collected genital samples to detect and quantify HPV. We performed a bivariate and a multivariate logistic regression analysis to identify correlates associated with the infection and to assess the viral load as a function of the viral infecting type. The fragments of β-globin gene and L1 of HPV, were amplified, purified and cloned, to evaluate viral load. Results: Among 253 subjects, HPV prevalence was 19.4%, and HPV16 was the most common subtype. History of STIs (OR = 4.8; 95% CI 1.2–18.9), contraceptive pill use by female partner (OR = 2.6; 95% CI 1.1–6.3) and exchanging sex for money (OR = 4.9; 95% CI 1.2–20) were associated to the HPV infection. HPV16 viral load was 7.8 copies (HPV/beta-globin) compared to 0.9 copies for other HPV types. Discussion: HPV16 displayed the highest viral load, and it was the most prevalent. It was found that using contraceptive pills by female partners was associated with HPV infection. .